Sitagliptin Phosphate Tablet, Film Coated
Product Images NDC 0781-5768

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin Phosphate (NDC 0781-5768). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sita-25-mg (25mg30slabel)

Sita-25-mg (25mg30slabel)
This text appears to be providing information about a medication called Sitagliptin. It includes details such as usual dosage, storage instructions, and a reminder to dispense the medication in a tight, light-resistant container. The text also instructs pharmacists to dispense the medication guide to each patient along with the tablets.*
FDA Label Image

Sita-50-mg (50mg30slabel)

Sita-50-mg (50mg30slabel)
This is a medication information for Sitagliptin tablets. Each film-coated tablet contains 64.25 mg of sitagliptin phosphate. Usual dosage information can be found in the package insert. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). They should be dispensed in a light-resistant container and kept out of reach of children. The medication guide must be given to each patient by the pharmacist.*
FDA Label Image

Chemicalstructureformula (Image 01)

FDA Label Image

Figure1 (Image 02)

Figure1 (Image 02)
This text provides information about the change from baseline measurements for different treatment groups over time in a study comparing the effects of Placebo, Sitagliptin 100 mg q.d., Metformin 500 mg bid, Metformin 1000 mg bid, Sitagliptin 50 mg bid + Metformin 500 mg bid, and Sitagliptin 50 mg bid + Metformin 1000 mg bid. It shows a comparison of different treatment weeks and dosages.*
FDA Label Image

Figure2 (Image 03)

Figure2 (Image 03)
The LS Mean Change from Baseline comparing Sitagliptin 100 mg to Glipizide is 1.2.*
FDA Label Image

Sita-100-mg (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.